Press Releases Cytosorbents Corporation

Equities

CTSO

US23283X2062

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.819 ^USD	+1.24%		+2.12%	-26.22%

Mar. 15	Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 14	Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CytoSorbents to Report First Quarter 2024 Operating and Financial Results	Apr. 26	GL
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting	Apr. 17	GL
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results	Mar. 14	GL
CytoSorbents to Report Fiscal 2023 Operating and Financial Results	Mar. 06	GL
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference	Feb. 08	GL
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference	Feb. 08	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	Jan. 30	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	Jan. 22	PR
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients	Jan. 17	GL
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients	Jan. 17	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	Jan. 14	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	Jan. 06	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	Dec. 29	PR
CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation	Dec. 28	GL
CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering	Dec. 13	GL
CytoSorbents: Q3 Earnings Snapshot	Nov. 09	AQ
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results	Nov. 09	GL
CytoSorbents to Report Third Quarter 2023 Operating and Financial Results	23-10-27	GL
CytoSorbents to Present at the 8th Annual Dawson James Conference	23-10-05	GL
CytoSorbents to Present at the 8th Annual Dawson James Conference	23-10-05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Cytosorbents Corporation

Equities

CTSO

US23283X2062

Press Releases

Filters